Beginning Cash (Annual)

Beginning Cash: The amount of cash reported by the company on its previous statement.

Abbott Laboratories (ABT) had Beginning Cash of $7.62B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$44.33B
Net Income	$6.52B
Cost of Goods Sold	$19.32B
Gross Profit	$25.01B
Operating Expenses	$36.27B
Operating Income	$8.05B
Non-Operating Income/Expense	$413.00M
Pre-Tax Income	$8.47B
Normalized Pre-Tax Income	$8.47B
Income after Taxes	$6.52B
Income from Continuous Operations	$6.52B
Consolidated Net Income/Loss	$6.52B
Normalized Income after Taxes	$6.52B
EBIT	$8.05B
EBITDA	$11.17B
Weighted-Average Shares Outstanding (Basic)	1.74B
Weighted-Average Shares Outstanding (Diluted)	1.75B
Earnings per Share (EPS) (Basic)	$3.73
Earnings per Share (EPS) (Diluted)	$3.72
Balance Sheet Financials
Current Assets	$26.00B
Property, Plant, and Equipment	$11.82B
Long-Term Assets	$60.72B
Total Assets	$86.71B
Current Liabilities	$16.50B
Long-Term Debt	$9.90B
Long-Term Liabilities	$17.45B
Total Liabilities	$33.94B
Common Equity	$52.77B
Tangible Shareholders Equity	$23.21B
Shareholders Equity	$52.77B
Common Shares Outstanding	1.74B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.57B
Cash Flow from Investing Activities	$-2.42B
Cash Flow from Financial Activities	$-6.31B
Beginning Cash	$7.62B
End Cash	$8.52B
Increase/Decrease in Cash	$906.00M
Stock-Based Compensation	$664.00M
Common Stock Dividends Paid	$-4.12B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.58
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.24
Gross Margin	56.42%
Operating Margin	18.17%
EBIT Margin	18.17%
EBITDA Margin	25.20%
Pre-Tax Profit Margin	19.10%
Profit Margin	14.72%
Free Cash Flow	$7.39B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.51
Inventory Turnover	2.98
Receiveable Turnover	5.59
Days Sales in Receivables	65.29
Return on Equity	12.36%
Return on Tangible Equity	28.11%
Return on Assets	7.52%
Return on Investments	10.41%
Book Value Per Share	$30.39
Free Cash Flow per Share	$4.23
Operating Cash Flow per Share	$5.47

Data from Zacks Investment Research, Inc.